RBC Capital reiterates Outperform on Corteva, $103 target
RBC Capital reiterated an Outperform rating on Corteva and set a $103.00 price target, implying 23.5% upside versus the Sep 15 close of $83.39.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.